Partial IL-10 Inhibition of the Cell-Mediated Immune Response in Chronic Beryllium Disease
Public Domain
-
1999/09/01
-
Details
-
Personal Author:
-
Description:Chronic beryllium disease (CBD) provides a human disorder in which to study the delayed type IV hypersensitivity response to persistent Ag that leads to noncaseating pulmonary granuloma formation. We hypothesized that, in CBD, failure of IL-10 to modulate the beryllium-specific, cell-mediated immune response would result in persistent, maximal cytokine production and T lymphocyte proliferation, thus contributing to the development of granulomatous lung disease. To test this hypothesis, we used bronchoalveolar lavage cells from control and CBD subjects to evaluate the beryllium salt-specific production of endogenous IL-10 and the effects of exogenous human rIL-10 (rhIL-10) on HLA expression, on the production of IL-2, IFN-gamma, and TNF-alpha, and on T lymphocyte proliferation. Our data demonstrate that beryllium-stimulated bronchoalveolar lavage cells produce IL-10, and the neutralization of endogenous IL-10 does not increase significantly cytokine production, HLA expression, or T lymphocyte proliferation. Second, the addition of excess exogenous rhIL-10 partially inhibited the beryllium-stimulated production of IL-2, IFN-gamma, and TNF-alpha; however, we measured no change in T lymphocyte proliferation or in the percentage of alveolar macrophages expressing HLA-DP. Interestingly, beryllium salts interfered with an IL-10-stimulated decrease in the percentage of alveolar macrophages expressing HLA-DR. We conclude that, in the CBD-derived, beryllium-stimulated cell-mediated immune response, low levels of endogenous IL-10 have no appreciable effect; exogenous rhIL-10 has a limited effect on cytokine production and no effect on T lymphocyte proliferation or HLA expression. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0022-1767
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:163
-
Issue:5
-
NIOSHTIC Number:nn:20025376
-
Citation:J Immunol 1999 Sep; 163(5):2747-2753
-
Contact Point Address:Dr. Sally S. Tinkle, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505
-
Email:sft3@cdc.gov
-
CAS Registry Number:
-
Federal Fiscal Year:1999
-
Peer Reviewed:True
-
Source Full Name:The Journal of Immunology
-
Collection(s):
-
Main Document Checksum:urn:sha-512:17f46176b6ec7769b44d0ac9891b0cbe26498e3eb7b200c453aab8bbc6083d696d0445d95f07a1c4d9df76887f09e69243e048599b1d31fa46cf0f2d8d8a94b1
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like